News

Experts investigate the role of IL-26 in COVID-19

0
3D render of a medical background with DNA strands

Researchers at Karolinska Institutet in Sweden have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease. The findings, which are presented in Frontiers in Immunology, indicate that IL-26 is a potential biomarker for severe COVID-19.

18 Chrome Extensions for Maximum Productivity

Previous article

Study concludes monkeypox virus is readily detected by qPCR using three clinically validated assays

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News